Literature DB >> 12461587

Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: a 10-year survey.

M Vriens1, H Blok, A Fluit, A Troelstra, C Van Der Werken, J Verhoef.   

Abstract

Although the Dutch policy to eradicate methicillin-resistant Staphylococcus aureus (MRSA) is very strict compared to policies employed in other countries, it has proven to be successful epidemiologically (incidence of MRSA in the Netherlands, <0.5%). The present study was performed to investigate both the financial and the logistical consequences of this strict, so-called "search and destroy" policy in the Netherlands. The data were based on a 10-year survey (1991-2000) of screening, surveillance, and outbreaks at the University Medical Center Utrecht. The consequences of the policy were determined by a panel comprising physicians from the Department of Surgery, the Department of Medical Microbiology, Subdivision Hospital Hygiene and Infection Prevention, the Department of Pharmacy, and Household Services. The costs associated with the policy were also calculated, including those for additional (disposable) material, cultures, specific medication, decontamination, and closing of the wards. Over the course of the 10 years, implementation of the MRSA policy resulted in more than 2,265 lost hospitalization days. In addition, the wards had to be closed 48 times, 29 healthcare workers had to temporarily discontinue working, and 78,000 additional cultures had to be performed. The total cost reached 6 million Dutch guilders (euro 2,800,000). The financial and logistical consequences were then compared to those in a hypothetical situation without the "search and destroy" policy. In such a situation, the hospital would be faced with an increased incidence of MRSA, vancomycin intermediate-susceptible Staphylococcus aureus, and vancomycin-resistant enterococci. The costs associated with the use of alternative antibiotics, required in a scenario of high endemic-level MRSA, would be at least twice as high as the costs expended in the actual situation, thus demonstrating that a strict MRSA policy is financially worthwhile.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12461587     DOI: 10.1007/s10096-002-0811-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  30 in total

1.  Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem.

Authors:  David L Smith; Jonathan Dushoff; Eli N Perencevich; Anthony D Harris; Simon A Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-25       Impact factor: 11.205

2.  Crafting a system-wide response to healthcare-associated infections.

Authors:  Ramanan Laxminarayan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

3.  Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing.

Authors:  M C J Bootsma; O Diekmann; M J M Bonten
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-24       Impact factor: 11.205

4.  Relationship of antimicrobial control policies and hospital and infection control characteristics to antimicrobial resistance rates.

Authors:  Elaine L Larson; Dave Quiros; Tara Giblin; Susan Lin
Journal:  Am J Crit Care       Date:  2007-03       Impact factor: 2.228

5.  Transmission dynamics of methicillin-resistant Staphylococcus aureus in a medical intensive care unit.

Authors:  Ian M Hall; Iain Barrass; Steve Leach; Didier Pittet; Stéphane Hugonnet
Journal:  J R Soc Interface       Date:  2012-05-09       Impact factor: 4.118

6.  Impact of methicillin-resistant Staphylococcus aureus infection on outcome after esophagectomy.

Authors:  David J Bowrey; Martyn D Evans; Geoffrey W B Clark
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

7.  Quantifying cost-effectiveness of controlling nosocomial spread of antibiotic-resistant bacteria: the case of MRSA.

Authors:  Marjan W M Wassenberg; G Ardine de Wit; Ben A van Hout; Marc J M Bonten
Journal:  PLoS One       Date:  2010-07-16       Impact factor: 3.240

8.  Costs and benefits of the MRSA Search and Destroy policy in a Dutch hospital.

Authors:  M M L van Rijen; J A J W Kluytmans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-07-18       Impact factor: 3.267

Review 9.  Epidemiology and economic impact of meticillin-resistant Staphylococcus aureus: review and analysis of the literature.

Authors:  Andrew F Shorr
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 10.  Rapid detection of methicillin-resistant Staphylococcus aureus directly from clinical samples: methods, effectiveness and cost considerations.

Authors:  Enno Stürenburg
Journal:  Ger Med Sci       Date:  2009-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.